NVTA logo

Invitae Corporation

NVTA

NVTA: Invitae Corp operates as a genetic information company in diagnostic and research industry. The company's tests include multiple genes associated with hereditary cancer, neurological disorders, cardiovascular disorders, pediatric disorders, metabolic disorders and other hereditary conditions.

more

Show NVTA Financials

All
Government
Consumer Interest
SEC Filings
ESG/Other

Recent trades of NVTA by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by NVTA's directors and management

Government lobbying spending instances

  • $90,000 Jul 10, 2023 Issue: Budget/Appropriations Health Issues Copyright/Patent/Trademark Medicare/Medicaid Medical/Disease Research/Clinical Labs
  • $90,000 Apr 17, 2023 Issue: Budget/Appropriations Health Issues Copyright/Patent/Trademark Medicare/Medicaid Medical/Disease Research/Clinical Labs
  • $90,000 Jan 03, 2023 Issue: Budget/Appropriations Consumer Issues/Safety/Products Health Issues Copyright/Patent/Trademark Medicare/Medicaid Medical/Disease Research/Clinical Labs
  • $90,000 Oct 17, 2022 Issue: Consumer Issues/Safety/Products Health Issues Copyright/Patent/Trademark Medicare/Medicaid Medical/Disease Research/Clinical Labs
  • $90,000 Jul 19, 2022 Issue: Consumer Issues/Safety/Products Health Issues Copyright/Patent/Trademark Medicare/Medicaid Medical/Disease Research/Clinical Labs
  • $90,000 Apr 20, 2022 Issue: Health Issues Copyright/Patent/Trademark Medicare/Medicaid Medical/Disease Research/Clinical Labs
  • $90,000 Jan 19, 2022 Issue: Medical/Disease Research/Clinical Labs Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark
  • $80,000 Oct 20, 2021 Issue: Budget/Appropriations Copyright/Patent/Trademark Health Issues Medical/Disease Research/Clinical Labs Medicare/Medicaid
  • $75,000 Jul 16, 2021 Issue: Medicare/Medicaid Budget/Appropriations Medical/Disease Research/Clinical Labs Copyright/Patent/Trademark
  • $20,000 Jun 23, 2021 Issue: Health Issues
  • $30,000 Apr 20, 2021 Issue: Health Issues
  • $75,000 Apr 15, 2021 Issue: Medicare/Medicaid Copyright/Patent/Trademark Medical/Disease Research/Clinical Labs
  • $30,000 Jan 20, 2021 Issue: Health Issues
  • $65,000 Jan 19, 2021 Issue: Budget/Appropriations Medicare/Medicaid Medical/Disease Research/Clinical Labs Copyright/Patent/Trademark Health Issues
  • $60,000 Oct 20, 2020 Issue: Medicare/Medicaid Budget/Appropriations Medical/Disease Research/Clinical Labs Health Issues
  • $30,000 Oct 16, 2020 Issue: Health Issues
  • $20,000 Jul 20, 2020 Issue: Health Issues
  • $60,000 Jul 20, 2020 Issue: Budget/Appropriations Health Issues Medical/Disease Research/Clinical Labs Medicare/Medicaid
  • $60,000 Apr 17, 2020 Issue: Medicare/Medicaid Budget/Appropriations Medical/Disease Research/Clinical Labs
  • $60,000 Jan 15, 2020 Issue: Copyright/Patent/Trademark Medicare/Medicaid Budget/Appropriations Medical/Disease Research/Clinical Labs
  • $58,000 Oct 11, 2019 Issue: Medicare/Medicaid Budget/Appropriations Medical/Disease Research/Clinical Labs Copyright/Patent/Trademark
  • $37,500 Jul 21, 2019 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid Budget/Appropriations Copyright/Patent/Trademark
  • $20,000 Apr 08, 2019 Issue: Budget/Appropriations Medical/Disease Research/Clinical Labs Medicare/Medicaid
  • $40,000 Mar 12, 2019 Issue: Health Issues
  • $40,000 Jan 18, 2019 Issue: Health Issues Budget/Appropriations
  • $40,000 Oct 19, 2018 Issue: Health Issues Budget/Appropriations
  • $40,000 Jul 18, 2018 Issue: Budget/Appropriations Health Issues
  • $40,000 Apr 16, 2018 Issue: Health Issues Budget/Appropriations
  • $40,000 Jan 22, 2018 Issue: Health Issues
  • $40,000 Oct 05, 2017 Issue: Health Issues
  • $40,000 Jul 19, 2017 Issue: Health Issues
  • $20,000 Apr 18, 2017 Issue: Health Issues
  • $20,000 Jul 14, 2015 Issue: None
  • $30,000 Apr 23, 2015 Issue: Health Issues
  • $10,000 Jan 16, 2015 Issue: Medical/Disease Research/Clinical Labs
  • $10,000 Jan 16, 2015 Issue: Medical/Disease Research/Clinical Labs
  • $10,000 Oct 16, 2014 Issue: Medical/Disease Research/Clinical Labs
U.S. Patents

New patents grants

  • Patent Title: Arrays for single molecule detection and use thereof Aug. 29, 2023
  • Patent Title: Sequence assembly Jun. 06, 2023
  • Patent Title: Methods, systems and processes of identifying genetic variation in highly similar genes Mar. 21, 2023
  • Patent Title: Molecular evidence platform for auditable, continuous optimization of variant interpretation in genetic and genomic testing and analysis Oct. 04, 2022
  • Patent Title: Sequence assembly Jul. 19, 2022
  • Patent Title: Assays for single molecule detection and use thereof May. 10, 2022
  • Patent Title: Systems and methods for quantification and presentation of medical risk arising from unknown factors Apr. 12, 2022
  • Patent Title: Systems and methods for single molecule quantification Feb. 22, 2022
  • Patent Title: Blood sampling system and method Nov. 09, 2021
  • Patent Title: Sequence assembly Oct. 26, 2021
  • Patent Title: Sequence assembly Oct. 19, 2021
  • Patent Title: Methods, systems and processes of identifying genetic variations May. 04, 2021
  • Patent Title: Universal blocking oligo system and improved hybridization capture methods for multiplexed capture reactions May. 12, 2020
  • Patent Title: Methods, systems and processes of identifying genetic variation in highly similar genes Aug. 27, 2019
  • Patent Title: Multiplex nucleic acid detection methods Apr. 18, 2017
  • Patent Title: Systems and methods for obtaining and managing sequencing data Dec. 03, 2013
Government Contracts

Federal grants, loans, and purchases

WallStreetBets

Number of mentions of NVTA in WallStreetBets Daily Discussion

NVTA News

Recent insights relating to NVTA

CNBC Recommendations

Recent picks made for NVTA stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in NVTA

Corporate Flights

Flights by private jets registered to NVTA